Business Standard

Sharon Bio-Medicine zooms on plans to launch profitable products

The company plans to introduce profitable products and expand presence in the US

Image

SI Reporter Mumbai
Shares of Sharon Bio-Medicine was locked in 20% upper circuit at Rs 11.62 on the Bombay Stock Exchange after the company's board at its meeting held on Tuesday discussed the current financial position and decided to introduce more profitable products and increase capacity utilization.

The release also said that the board discussed plans to expand the company's presence in the regulated markets specifically the United States of America.

The stock opened at Rs 9.98 and touched a high of Rs 11.62. At 10:15am, over 850,000 shares were traded on both the stock exchanges.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 22 2016 | 10:17 AM IST

Explore News